On Monday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) was -7.87% drop from the session before, before settling in for the closing price of $16.14. A 52-week range for DNA has been $5.00 – $16.85.
Healthcare Sector giant saw their annual sales slid by -27.97% over the last five years. When this article was written, the company’s average yearly earnings per share was at 50.15%. With a float of $40.53 million, this company’s outstanding shares have now reached $43.82 million.
Ginkgo Bioworks Holdings Inc (DNA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ginkgo Bioworks Holdings Inc stocks. The insider ownership of Ginkgo Bioworks Holdings Inc is 27.89%, while institutional ownership is 61.91%. The most recent insider transaction that took place on Oct 01 ’25, was worth 84,135. In this transaction an insider of this company sold 5,609 shares at a rate of $15.00, taking the stock ownership to the 5,503 shares. Before that another transaction happened on Sep 09 ’25, when Company’s Director sold 10,000 for $11.06, making the entire transaction worth $110,600. This insider now owns 24,310 shares in total.
Ginkgo Bioworks Holdings Inc (DNA) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -1.08 earnings per share (EPS) during the time that was better than consensus figure (set at -3.32) by 2.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.15% per share during the next fiscal year.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Trading Performance Indicators
You can see what Ginkgo Bioworks Holdings Inc (DNA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.41. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.85, a number that is poised to hit -1.24 in the next quarter and is forecasted to reach -4.35 in one year’s time.
Technical Analysis of Ginkgo Bioworks Holdings Inc (DNA)
Analysing the last 5-days average volume posted by the [Ginkgo Bioworks Holdings Inc, DNA], we can find that recorded value of 2.32 million was better than the volume posted last year of 1.56 million. As of the previous 9 days, the stock’s Stochastic %D was 82.71%.
During the past 100 days, Ginkgo Bioworks Holdings Inc’s (DNA) raw stochastic average was set at 80.83%, which indicates a significant increase from 68.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.12 in the past 14 days, which was higher than the 0.91 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.40, while its 200-day Moving Average is $10.07. Now, the first resistance to watch is $15.95. This is followed by the second major resistance level at $17.02. The third major resistance level sits at $17.59. If the price goes on to break the first support level at $14.31, it is likely to go to the next support level at $13.74. Now, if the price goes above the second support level, the third support stands at $12.67.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Key Stats
There are 59,200K outstanding shares of the company, which has a market capitalization of 880.30 million. As of now, sales total 227,040 K while income totals -547,030 K. Its latest quarter income was 49,600 K while its last quarter net income were -60,300 K.
